The strategy for the management of type 2 diabetes was updated in 2018 in response to the abundance of new cardiovascular outcome data from the CVOTs published since 2015, which showed safety, tolerability, and cardiovascular and renoprotection with 2 classes of agents, sodium glucose cotransporter 2 inhibitors (SGLT2i) and glucagon-like peptide receptor agonists (GLP1RA) in patients with established CVD (11)
Tanaka (89) reported through clinical studies that GLP-1RA in combination with metformin could inhibit the proliferation and induce the apoptosis of breast cancer cells
Surgery is frequently required to completely resolve the condition of gynecomastia, as weight loss from semaglutide treatment cannot eradicate the glandular tissue that defines this condition
There are several reasons people might want to switch: Weight loss plateaus after a few months on semaglutide Gastrointestinal side effects like nausea or constipation that are not manageable Desire for better glucose control Personal goals (e.g., prefer faster weight loss progress ) In my practice, the most common reasons I recommend patients to switch medication is 1) they are having uncomfortable or unmanageable side effects from semaglutide including heart burn, nausea, constipation or 2) their weight loss starts to plateau before they reach their weight loss goals
Q6. Does L-Carnitine contain caffeine or stimulants